155 related articles for article (PubMed ID: 9323473)
1. Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict.
Bougnoux ME; Dupont C; Turner L; Rouveix E; Dorra M; Nicolas-Chanoine MH
Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):598-600. PubMed ID: 9323473
[TBL] [Abstract][Full Text] [Related]
2. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
3. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
[TBL] [Abstract][Full Text] [Related]
4. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
5. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
6. Candida dubliniensis fungemia and vascular access infection.
Cimolai N; Davis J; Trombley C
J Pediatr Hematol Oncol; 2002; 24(3):237-9. PubMed ID: 11990315
[TBL] [Abstract][Full Text] [Related]
7. Candidemia: a nosocomial complication in adults with late-stage AIDS.
Launay O; Lortholary O; Bouges-Michel C; Jarrousse B; Bentata M; Guillevin L
Clin Infect Dis; 1998 May; 26(5):1134-41. PubMed ID: 9597242
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotype.
Odds FC; Palacio-Hernanz A; Cuadra J; Sanchéz J
J Med Microbiol; 1987 May; 23(3):275-7. PubMed ID: 3295247
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Candida albicans isolates from heroin addicts analysed by DNA typing.
McCullough MJ; Clemons KV; Del Palacio A; Stevens DA
Med Mycol; 1998 Aug; 36(4):213-7. PubMed ID: 9776837
[TBL] [Abstract][Full Text] [Related]
10. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
[TBL] [Abstract][Full Text] [Related]
11. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
[TBL] [Abstract][Full Text] [Related]
12. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals.
Miyasaki SH; Hicks JB; Greenspan D; Polacheck I; MacPhail LA; White TC; Agabian N; Greenspan JS
J Acquir Immune Defic Syndr (1988); 1992 Oct; 5(10):1039-46. PubMed ID: 1453319
[TBL] [Abstract][Full Text] [Related]
13. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
[TBL] [Abstract][Full Text] [Related]
14. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H
Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815
[No Abstract] [Full Text] [Related]
15. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Guinea J; Zaragoza Ó; Escribano P; Martín-Mazuelos E; Pemán J; Sánchez-Reus F; Cuenca-Estrella M;
Antimicrob Agents Chemother; 2014; 58(3):1529-37. PubMed ID: 24366741
[TBL] [Abstract][Full Text] [Related]
16. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
19. [Phenotypic evaluation to differentiate Candida albicans from Candida dubliniensis].
Mesa LM; Arcaya N; Cañas O; Machado Y; Calvo B
Rev Iberoam Micol; 2004 Sep; 21(3):135-8. PubMed ID: 15709787
[TBL] [Abstract][Full Text] [Related]
20. Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis.
Blumberg HM; Hendershot EF; Lott TJ
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):545-7. PubMed ID: 1424508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
